Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Imeron
2. Iomeprol 350
3. Iomeprol 400
4. Iomeron
1. 78649-41-9
2. Iomeprolum
3. Iomeron
4. Imeron
5. Iomeron 300
6. N,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(n-methylglycolamido)isophthalamide
7. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-methylacetamido)-2,4,6-triiodoisophthalamide
8. E-7337
9. 1-n,3-n-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide
10. 17e17jbp8l
11. 1185146-41-1
12. Chebi:31710
13. N,n'-bis(2,3-dihydroxypropyl)-5-[glycoloyl(methyl)amino]-2,4,6-triiodoisophthalamide
14. Ncgc00183283-01
15. Iomeprolo
16. E7337
17. 1,3-benzenedicarboxamide, N,n'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)methylamino)-2,4,6-triiodo-
18. Iomeprolum [inn-latin]
19. Unii-17e17jbp8l
20. Iomeprol [usan:inn:ban:jan]
21. Iomeprol [usan]
22. Iomeprol [inn]
23. Iomeprol [jan]
24. Iomeprol [mi]
25. Iomeron 300 (tn)
26. Iomeprol [mart.]
27. Iomeprol [who-dd]
28. Dsstox_cid_28987
29. Dsstox_rid_83252
30. Dsstox_gsid_49061
31. Schembl26981
32. Iomeprol (jan/usan/inn)
33. Chembl2107214
34. Dtxsid1049061
35. Bcp34386
36. Tox21_113611
37. Akos030255901
38. Db11705
39. Ac-30722
40. Cas-78649-41-9
41. Db-056324
42. Ft-0627277
43. Ft-0670399
44. Methylacetamido)-2,4,6-triiodoisophthalamide
45. D01719
46. Iomeprol 100 Microg/ml In Acetonitrile/methanol
47. Iomeprol 100 Microg/ml In Acetonitrile:methanol
48. A839467
49. B-16880
50. N1,n3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-n-
51. Q6062808
52. 1,3-benzenedicarboxamide, N1,n3-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)methylamino]-2,4,6-triiodo-
| Molecular Weight | 777.1 g/mol |
|---|---|
| Molecular Formula | C17H22I3N3O8 |
| XLogP3 | -2.3 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 10 |
| Exact Mass | 776.8541 g/mol |
| Monoisotopic Mass | 776.8541 g/mol |
| Topological Polar Surface Area | 180 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 591 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
V08AB10
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
V - Various
V08 - Contrast media
V08A - X-ray contrast media, iodinated
V08AB - Watersoluble, nephrotropic, low osmolar x-ray contrast media
V08AB10 - Iomeprol
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Imeron 300 100ML
Dosage Form : INJ
Dosage Strength : 612mg/ml
Packaging : 300X10mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Imeron 350 200 ML
Dosage Form : INJ
Dosage Strength : 714mg/ml
Packaging : 350X10mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : RX
Registration Country : USA
Brand Name : IOMERVU
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 30GM IODINE/100ML (300MG IODINE/ML)
Packaging :
Approval Date : 2024-11-27
Application Number : 216016
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IOMERVU
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 52.5GM IODINE/150ML (350MG IODINE/ML
Packaging :
Approval Date : 2024-11-27
Application Number : 216016
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IOMERVU
Dosage Form : SOLUTION;INTRA-ARTERIAL
Dosage Strength : 80GM IODINE/200ML (400MG IODINE/ML)
Packaging :
Approval Date : 2024-11-27
Application Number : 216016
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IOMERVU
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60GM IODINE/150ML (400MG IODINE/ML)
Packaging :
Approval Date : 2024-11-27
Application Number : 216017
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Iomeron
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 150 MG I / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Iomeron 400
Dosage Form : Iomeprol 60.000Mg 150Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle EV 150 ml 400 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Iomeron 350
Dosage Form : Iomeprol 87.500Mg 250Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle EV 250 ml 350 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Iomeron
Dosage Form : Injection fluid, resolution
Dosage Strength : 250 mg IN/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
A Iomeprol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iomeprol, including repackagers and relabelers. The FDA regulates Iomeprol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iomeprol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Iomeprol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Iomeprol supplier is an individual or a company that provides Iomeprol active pharmaceutical ingredient (API) or Iomeprol finished formulations upon request. The Iomeprol suppliers may include Iomeprol API manufacturers, exporters, distributors and traders.
click here to find a list of Iomeprol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Iomeprol DMF (Drug Master File) is a document detailing the whole manufacturing process of Iomeprol active pharmaceutical ingredient (API) in detail. Different forms of Iomeprol DMFs exist exist since differing nations have different regulations, such as Iomeprol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Iomeprol DMF submitted to regulatory agencies in the US is known as a USDMF. Iomeprol USDMF includes data on Iomeprol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Iomeprol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Iomeprol suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Iomeprol Drug Master File in Korea (Iomeprol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Iomeprol. The MFDS reviews the Iomeprol KDMF as part of the drug registration process and uses the information provided in the Iomeprol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Iomeprol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Iomeprol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Iomeprol suppliers with KDMF on PharmaCompass.
Iomeprol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iomeprol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iomeprol GMP manufacturer or Iomeprol GMP API supplier for your needs.
A Iomeprol CoA (Certificate of Analysis) is a formal document that attests to Iomeprol's compliance with Iomeprol specifications and serves as a tool for batch-level quality control.
Iomeprol CoA mostly includes findings from lab analyses of a specific batch. For each Iomeprol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iomeprol may be tested according to a variety of international standards, such as European Pharmacopoeia (Iomeprol EP), Iomeprol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iomeprol USP).
LOOKING FOR A SUPPLIER?
